Researchers from the University of Glasgow are expanding their research into bioprinting, with their findings outlined in the recently published ‘Bacteria laden microgels as autonomous 3D environments for stem cell engineering.’ The team has developed a microfluidic system comprised of one step, allowing both stem cells and genetically engineered non-pathogenic bacteria to be contained in an alginate microgel.
While most techniques rely on droplet extrusion, here the researchers are creating a more efficient system via a one-step droplet microfluidic method. Fabrication of the pearl-lace microgels occurs at physiological pH without any sheathing material, with channel dimensions and overall design meant to avoid shear stress on the cells and encourage viability.
“The fabricated gel-construct is unique in a way that it has both compartmentalized units as in individual microcapsules as well as the connectivity found in fibrous constructs,” state the researchers. “It is also noted that the compartmentalized microunits and the link connecting them are highly tunable resulting in highly mono-dispersed pearl-lace interlinking structures.”
For this project, the researchers created an in vitro 3D model ‘for investigating the commensalism symbiosis between eukaryotic (bone marrow mesenchymal stem cells, hBM-MSC) and prokaryotic cells (engineered non-pathogenic bacteria Lactococcus lactis, L. lactis).’
While bacteria are commonly used as an affordable ‘production organism’ for proteins in bioprinting, they can also act as a mechanism for directing both cell growth and differentiation. The researchers also used a bacteriostatic antibiotic, sulfamethoxazole, to prevent growth of harmful bacteria.
Four 3D printed shapes were fabricated, including a line, triangle, square, and circle, and arrangement as follows:
- Line – two circular discs (180-degree angle)
- Three for triangle (60-degree internal angle)
- Four for square (90-degree internal angle)
- Eight for a circle-like shape (135-degree internal angle, octagon)
The microfluidic systems allowed the researchers to create ‘mono-disperse’ constructs which are suitable for applications like pharmacological screenings, biological studies, and personalized medicine.
“The connectivity of pearl-lace hydrogels can provide a way of gradient studies in which the population of each cell type and so its relative density can be controlled. It can also be utilized for time-series indexing studies as well as providing a mean for a low-cost, easy to fabricate 3D bio-printing prototypes as demonstrated in this study,” concluded the researchers.
“Microgel in this study has been utilized as a proof of concept for modeling a tuneable platform in which both hydrogel acting as an ECM as well as production and release of growth factor can be both engineered at a low cost with high precision spatio-temporal control. It has been an attempt to further engineer more aspects of an in vitro system, paving the way for study of cells and their interaction with adjustable dynamic ECM-like environment with greater control. “
As the progress of bioprinting continues to take hold in global research, scientists create new bioprinting inks, 3D printed microsurfaces, progressive microfluidic techniques, and more. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: Bacteria laden microgels as autonomous 3D environments for stem cell engineering]
You May Also Like
Cartilage Tissue Engineering via Characterization and Application of Carboxymethyl Chitosan-Based Bioink
International researchers continue the trend in exploring natural biomaterials for bioprinting, detailing their findings in the recently published ‘Characterization and Application of Carboxymethyl Chitosan-Based Bioink in Cartilage Tissue Engineering.’ Examining...
Review: Current Efforts in 3D Printed Pharmaceuticals and Drug-Delivery Systems
International researchers continue to explore the potential of patient-specific treatment via 3D printing, releasing their findings regarding pharmaceuticals in the recently published ‘3D Printing of Pharmaceuticals and Drug Delivery Devices.’...
Regemat3D Launches its New Bioreactors for Maturing Tissues
One of Spain’s leading biotech companies, Regemat3D, has been developing custom biofabrication systems and regenerative medicine solutions since 2011 to fulfill unique research requirements and offer customized solutions for patients’...
Nanyang Technological University: Thesis Validates Use of Bessel Beams in Laser-Based 3D Printing
Andy Wen Loong Liew has submitted a thesis, ‘Laser-based 3D printing using bessel beams for tissue engineering applications’ to Nanyang Technological University. Exploring a new technique for bioprinting, Liew studies...
View our broad assortment of in house and third party products.